Announcements Trials
Browse Landscape

Phase

Phase 2 82Phase 3 27Phase 1 23Phase 1/2 19Phase NA 4Phase 2/3 4Phase EARLY_PHASE1 2

Status

Recruiting 2Completed 2

Sponsor Class

INDUSTRY 2OTHER 1NETWORK 1

Study Type

Interventional 4

Sponsor

Cancer Type

Thoracic 21Breast 12Gynecologic 11Genitourinary 4Head & Neck 3CNS 3Other solid neoplasm 2Lymphoid 2Tumor-Agnostic 1Sarcoma 1Other neoplasm 1Other hematologic neoplasm 1Myeloid 1Gastrointestinal 1Endocrine 1Dermatologic 1Classical hematology 1

Conditions

Urinary Bladder Neoplasms 3Urethral Neoplasms 1Carcinoma, Transitional Cell 1Advanced Urothelial Cancer 1

Interventions

Gemcitabine 9Docetaxel 8Androgen Antagonists 7acetyl-2-naphthylalanyl-3-chlorophenylalanyl-1-oxohexadecyl-seryl-4-aminophenylalanyl(hydroorotyl)-4-aminophenylalanyl(carbamoyl)-leucyl-ILys-prolyl-alaninamide 6Magnetic Resonance Spectroscopy 6gallium 68 PSMA-11 5Prednisone 5Leuprolide 5Goserelin 5Cisplatin 5enzalutamide 4bicalutamide 4Triptorelin Pamoate 4Radiosurgery 4Carboplatin 42-(3-(1-carboxy-5-((6-fluoropyridine-3-carbonyl)amino)pentyl)ureido)pentanedioic acid 4luprolide acetate gel depot 3Flutamide 3Celecoxib 3valrubicin 2pembrolizumab 2nilutamide 2cabazitaxel 2abiraterone 2Zoledronic Acid 2Vinblastine 2Specimen Handling 2Radiotherapy, Intensity-Modulated 2Radiotherapy 2Nivolumab 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Phase 2/3 × Carboplatin × Genitourinary × Clear all
NCT07129993 2026-05-14

Study of Datopotamab Deruxtecan Plus Carboplatin or Cisplatin Versus Gemcitabine Plus Carboplatin or Cisplatin in Participants With Locally Advanced or Metastatic Urothelial Carcinoma

Daiichi Sankyo

Phase 2/3 Recruiting
630 enrolled
Genitourinary

Urinary Bladder Neoplasms, Carcinoma, Transitional Cell

NCT07106762 2026-05-12

Phase 2/3 Trial of Izalontamab Brengitecan vs Platinum-based Chemotherapy for Metastatic Urothelial Cancer With Disease Progression on or After Immunotherapy

Bristol-Myers Squibb

Phase 2/3 Recruiting
470 enrolled
Genitourinary

Urinary Bladder Neoplasms

NCT02240017 2019-08-09

VEFORA

Institut Claudius Regaud

Phase 2/3 Completed
46 enrolled
Genitourinary

Advanced Urothelial Cancer

NCT00014274 2013-06-12

Combination Chemotherapy in Treating Patients With Transitional Cell Cancer of the Urothelium

European Organisation for Research and Treatment of Cancer - EORTC

Phase 2/3 Completed
238 enrolled
Genitourinary

Urinary Bladder Neoplasms, Urethral Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡